Johan Törlén

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Anknuten, disputerat vid Karolinska Institutet 2019. Specialistläkare i
hematologi och biträdande överläkare inom medicinska enheten Cellterapi och Allogen
Stamcellstransplantation (CAST) på Karolinska Universitetssjukhuset

Artiklar

Article: TRANSPLANTATION AND CELLULAR THERAPY. 2023;29(6):376.e1-376.e11

Effect of mTOR Inhibition with Sirolimus on Natural Killer Cell Reconstitution in Allogeneic Stem Cell Transplantation.

Haroun-Izquierdo A; Lanuza PM; Pfefferle A; Netskar H; Ask EH; Törlén J; Björklund A; Sohlberg E; Malmberg K-J
Article: FRONTIERS IN IMMUNOLOGY. 2022;13:954716

T cell receptor excision circles are potential predictors of survival in adult allogeneic hematopoietic stem cell transplantation recipients with acute myeloid leukemia.

Söderström A; Vonlanthen S; Jönsson-Videsäter K; Mielke S; Lindahl H; Törlén J; Uhlin M
Article: ORAL DISEASES. 2021;27(5):1217-1225

Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft-versus-host disease prophylaxis.

Garming Legert K; Ringdén O; Remberger M; Törlén J; Mattsson J; Dahllöf G
Article: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2021;113(5):712-722

Cytokine levels following allogeneic hematopoietic cell transplantation: a match-pair analysis of home care versus hospital care.

Ringdén O; Remberger M; Törlén J; Finnbogadottir S; Svahn B-M; Sadeghi B
Article: CTS-CLINICAL AND TRANSLATIONAL SCIENCE. 2020;13(2):293-300

Reduced Risk of Sinusoidal Obstruction Syndrome of the Liver after Busulfan-Cyclophosphamide Conditioning Prior to Allogeneic Hematopoietic Stem Cell Transplantation.

El-Serafi I; Remberger M; Ringdèn O; Törlén J; Sundin M; Björklund A; Winiarski J; Mattsson J
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2019;25(6):1260-1268

Effect of Graft-versus-Host Disease Prophylaxis Regimens on T and B Cell Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation.

Törlén J; Gaballa A; Remberger M; Mörk L-M; Sundberg B; Mattsson J; Uhlin M
Article: FRONTIERS IN IMMUNOLOGY. 2019;10:189

Individualization of Hematopoietic Stem Cell Transplantation Using Alpha/Beta T-Cell Depletion.

Rådestad E; Sundin M; Törlén J; Thunberg S; Önfelt B; Ljungman P; Watz E; Mattsson J; Uhlin M
Article: INTERNATIONAL JOURNAL OF HEMATOLOGY. 2017;106(4):471-475

Toxicological effects of fludarabine and treosulfan conditioning before allogeneic stem-cell transplantation.

Remberger M; Törlen J; Serafi IE; Garming-Legert K; Björklund A; Ljungman P; Sundin M; Hassan M; Mattsson J
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2017;23(4):677-683

Impact of Pretransplantation Indices in Hematopoietic Stem Cell Transplantation: Knowledge of Center-Specific Outcome Data Is Pivotal before Making Index-Based Decisions.

Törlén J; Remberger M; Le Blanc K; Ljungman P; Mattsson J
Article: FRONTIERS IN IMMUNOLOGY. 2017;8:717

Combining Flow and Mass Cytometry in the Search for Biomarkers in Chronic Graft-versus-Host Disease.

Stikvoort A; Chen Y; Rådestad E; Törlén J; Lakshmikanth T; Björklund A; Mikes J; Achour A; Gertow J; Sundberg B; Remberger M; Sundin M; Mattsson J; Brodin P; Uhlin M
Article: HAEMATOLOGICA. 2016;101(11):1417-1425

A prospective randomized trial comparing cyclosporine/methotrexate and tacrolimus/sirolimus as graft-versus-host disease prophylaxis after allogeneic hematopoietic stem cell transplantation.

Törlén J; Ringdén O; Garming-Legert K; Ljungman P; Winiarski J; Remes K; Itälä-Remes M; Remberger M; Mattsson J
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2016;22(9):1684-1689

Risk Factors for Invasive Mold Infections and Implications for Choice of Prophylaxis after Allogeneic Stem Cell Transplantation.

Blennow O; Remberger M; Törlén J; Szakos A; Ljungman P; Mattsson J
Article: TRANSPLANT INFECTIOUS DISEASE. 2015;17(6):785-794

Prolonged outbreak of adenovirus A31 in allogeneic stem cell transplant recipients.

Swartling L; Allard A; Törlen J; Ljungman P; Mattsson J; Sparrelid E
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2015;21(5):889-893

Effect of Total Nucleated and CD34(+) Cell Dose on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation.

Remberger M; Törlén J; Ringdén O; Engström M; Watz E; Uhlin M; Mattsson J
Article: TRANSPLANTATION AND CELLULAR THERAPY. 2014;20(9):1418-1425

Low CD34 dose is associated with poor survival after reduced-intensity conditioning allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndrome.

Törlén J; Ringdén O; Le Rademacher J; Batiwalla M; Chen J; Erkers T; Ho V; Kebriaei P; Keever-Taylor C; Kindwall-Keller T; Lazarus HM; Laughlin MJ; Lill M; O'Brien T; Perales M-A; Rocha V; Savani BN; Szwajcer D; Valcarcel D; Eapen M
Article: PEDIATRIC TRANSPLANTATION. 2014;18(4):398-404

Home care during neutropenia after allogeneic hematopoietic stem cell transplantation in children and adolescents is safe and may be more advantageous than isolation in hospital.

Ringdén O; Remberger M; Törlén J; Engström M; Fjaertoft G; Mattsson J; Svahn B-M

Alla övriga publikationer

Review: SUPPORTIVE CARE IN CANCER. 2023;31(12):702

Incidence, severity, and temporal development of oral complications in pediatric allogeneic hematopoietic stem cell transplant patients - a multicenter study.

Agholme MB; Dahllöf G; Törlén JK; Majorana A; Brennan MT; von Bültzingslöwen I; Tan PL; Hu S; Sim YF; Hong C
Editorial comment: CLINICAL PHARMACOLOGY & THERAPEUTICS. 2020;107(2):308

Protocol Changes Lead to Lowering of SOS Rates
Conference publication: BONE MARROW TRANSPLANTATION. 2020;55(SUPPL 1):336

Cytokine Levels following Allogeneic Hematopoietic Stem Cells Transplantation. A match-pair Analysis of Home Care Versus Hospital Care

Ringden O; Remberger M; Torlen J; Finnbogadottir S; Svahn B-M; Sadeghi B
Thesis / dissertation: 2019

From risk indices to reconstitution of immunity : studies of outcome-related factors in patients undergoing allogeneic hematopoietic stem cell transplantation

Karlsson Törlén, Johan
Conference publication: BONE MARROW TRANSPLANTATION. 2017;52:S338-S339

Toxicological side effects of fludarabin and treosulfan conditioning before allogeneic stem-cell transplantation

Mattsson J; Torlen J; El Serafi I; Legert KG; Bjorklund A; Ljungman P; Sundin M; Hassan M; Remberger M
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2017;86(4):264

Identifying cellular subsets diagnostic for severity chronic GVHD

Stikvoort A; Chen Y; Radestad E; Karlsson-Torlen J; Tadepally L; Bjorklund A; Mikes J; Achour A; Gertow J; Sundberg B; Remberger M; Sundin M; Mattsson J; Brodin P; Uhlin M
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2016;22(3):S415

Identifying Cellular Subsets Diagnostic for Severity and Organ Specific Chronic GVHD

Stikvoort A; Rodestad E; Gertow J; Torlen J; Sundin M; Mattsson J; Uhlin M
Conference publication: BONE MARROW TRANSPLANTATION. 2016;51:S21

A prospective randomized study comparing tacrolimus and sirolimus versus cyclosporine and methotrexate as gvhd prophylaxis in allogeneic hematopoietic stem cell transplantation

Torlen J; Ringden O; Garming-Legert K; Ljungman P; Winiarski J; Remes K; Itala-Remes M; Remberger M; Mattsson J
Conference publication: EUROPEAN JOURNAL OF IMMUNOLOGY. 2016;46:844

Identifying cellular subsets diagnostic for severity and organ specificity chronic GVHD

Stikvoort A; Chen Y; Radestad E; Torlen J; Sundberg B; Sundin M; Mattsson J; Brodin P; Uhlin M
Meeting abstract: TRANSPLANTATION AND CELLULAR THERAPY. 2015;21(2):S351

An Increasing Severity of Chronic GvHD Is Associated to an Activated and Cytotoxic T Cell Mediated Immune-Phenotype

Stikvoort A; Radestad E; Torlen J; Mattsson J; Uhlin M
Conference publication: BONE MARROW TRANSPLANTATION. 2015;50:S77

Prolonged Outbreak of Adenovirus A31 Among Allogeneic Stem Cell Transplant Recipients

Swartling LP; Allard A; Torlen J; Ljungman P; Mattsson J; Sparrelid E

Anställningar

Anknuten till Forskning, Medicin, Huddinge, Karolinska Institutet, 2024-2025
Anknuten till Forskning, Klinisk vetenskap, intervention och teknik, Karolinska Institutet, 2022-2025

Examina och utbildning

Medicine Doktorsexamen, Institutionen för onkologi-patologi, Karolinska Institutet, 2019
Läkarexamen, Karolinska Institutet, 2008

Om mig

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI